Kolmar BNH Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 484

Employees

  • Stock Symbol
  • 200130

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $5.63
  • (As of Friday Closing)

Kolmar BNH General Information

Description

Kolmar BNH Co Ltd is a Korea-based company, engaged in develops core ingredients for health functional foods and cosmetics. The company commercialize materials developed using natural products and produce and sell health functional foods and cosmetics through ODM/OEM methods. The company is engaged in ODM/OEM businesses for various health functional foods and cosmetics, focusing on improving immune function, gut health, and blood sugar levels. The company derives maximum revenue from health functional food business. The company exports its products in China, the United States, Taiwan, Russia, and Japan.

Contact Information

Formerly Known As
Sun Bio Tech
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 18, Saimdang-ro, Seocho-dong, Seocho-gu
  • Seoul, 06641
  • South Korea
+82
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
KRX
Corporate Office
  • 18, Saimdang-ro, Seocho-dong, Seocho-gu
  • Seoul, 06641
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kolmar BNH Stock Performance

As of 20-Nov-2026, Kolmar BNH’s stock price is $5.63. Its current market cap is $159M with 28.3M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.63 $5.75 $4.94 - $10.59 $159M 28.3M 71K -$0.04

Kolmar BNH Financials Summary

As of 30-Jun-2026, Kolmar BNH has a trailing 12-month revenue of $371M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 167,214 328,364 330,644 488,047
Revenue 370,835 403,956 451,206 443,269
EBITDA 16,953 (346) 34,526 34,422
Net Income (1,075) (15,929) 13,231 15,075
Total Assets 369,855 451,169 469,031 538,930
Total Debt 72,491 149,640 152,671 161,501
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kolmar BNH Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kolmar BNH‘s full profile, request access.

Request a free trial

Kolmar BNH Patents

Kolmar BNH Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026135373-A1 Composition for enhancing immunity Pending 20-Dec-2024
AU-2025374364-A1 Composition for enhancing immunity comprising enzyme-treated product of polysaccharides or purified fraction thereof Pending 20-Dec-2024
EP-4789551-A1 Composition for enhancing immunity comprising enzyme-treated product of polysaccharides or purified fraction thereof Pending 20-Dec-2024
WO-2026135371-A1 Composition for enhancing immunity comprising enzyme-treated product of polysaccharides or purified fraction thereof Pending 20-Dec-2024
EP-4837428-A1 Composition for enhancing immunity comprising polysaccharide enzyme-treated product or purified fraction thereof Pending 20-Dec-2024 A23L33/105
To view Kolmar BNH’s complete patent history, request access »

Kolmar BNH Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kolmar BNH Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kolmar BNH‘s full profile, request access.

Request a free trial

Kolmar BNH Investments (1)

Kolmar BNH’s most recent deal was a Later Stage VC with PlanTFarm for . The deal was made on 14-Jul-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PlanTFarm 14-Jul-2021 Later Stage VC Other Agriculture
To view Kolmar BNH’s complete investments history, request access »

Kolmar BNH ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

30.99 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Household Products

Industry

of 104

Rank

Percentile

Personal Products

Subindustry

of 84

Rank

Percentile

To view Kolmar BNH’s complete esg history, request access »

Kolmar BNH FAQs

  • When was Kolmar BNH founded?

    Kolmar BNH was founded in 2004.

  • Where is Kolmar BNH headquartered?

    Kolmar BNH is headquartered in Seoul, South Korea.

  • What is the size of Kolmar BNH?

    Kolmar BNH has 484 total employees.

  • What industry is Kolmar BNH in?

    Kolmar BNH’s primary industry is Pharmaceuticals.

  • Is Kolmar BNH a private or public company?

    Kolmar BNH is a Public company.

  • What is Kolmar BNH’s stock symbol?

    The ticker symbol for Kolmar BNH is 200130.

  • What is the current stock price of Kolmar BNH?

    As of 20-Nov-2026 the stock price of Kolmar BNH is $5.63.

  • What is the current market cap of Kolmar BNH?

    The current market capitalization of Kolmar BNH is $159M.

  • What is Kolmar BNH’s current revenue?

    The trailing twelve month revenue for Kolmar BNH is $371M.

  • What is Kolmar BNH’s annual earnings per share (EPS)?

    Kolmar BNH’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process